Protein nitration in Parkinson's disease

Journal of Neuropathology and Experimental Neurology

Volumn 57, Issue 4, 1998, Pages 338-342

  Good, Paul F ^a   Hsu, Amy ^a   Werner, Peter ^a   Perl, Daniel P ^a   Warren Olanow, C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Excitotoxicity; Lewy body; Nitrotyrosine; Oxidative stress; Parkinson's disease

Indexed keywords

NITRIC OXIDE; PEROXYNITRATE; SUPEROXIDE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE DEGENERATION; NEUROFILAMENT; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN MODIFICATION;

EID: 0031939204     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199804000-00006     Document Type: Article

References (23)

1. Olanow CW, Arendash GW. Metals and free radicals in neurodegeneration. Curr Opinion Neurol 1994;7:548-58
2. Sian J, Dexter DT, Lees AJ, et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 1994;36:348-55
3. Dexter DT, Carter CJ, Wells FR, et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 1989;52:381-89
4. Sanchez-Ramos JR, Overvik E, Ames BN. A marker of oxyradicalmediated DNA damage (8-hydroxy-2′-deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain. Neurodegen 1994;3:97-204
5. Jellinger K, Kienzl E, Rumpelmair G, et al. Iron-melanin complex in substantia nigra of parkinsonian brains: An X-ray microanalysis. J Neurochem 1992;59:68-71
6. Good PF, Olanow CW, Perl DP. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: A LAMMA study. Brain Res 1992;593:343-46
7. Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990;54:823-27
8. Ischiropoulus H, Zhu L, Chen J, et al. Peroxynitrite-mediated tyrosine nitration catalyzed by Superoxide dismutase. Arch Biochem Biophys 1992;298:431-37
9. Lafon-Cazal M, Culcasi M, Gaven F, Pietri S, Bockaert J. Nitric oxide, Superoxide and peroxynitrite: Putative mediators of NMDA-induced cell death in cerebellar granule cells. Neuropharm 1993;32:259-66
10. Beckman JS, Ye YZ, Anderson PG, et al. Excessive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler 1994;375:81-88
11. Beckman JS. Peroxynitrite, Superoxide dismutase, and tyrosine nitration in neurodegeneration. Neurodegenerative Diseases '95: Molecular and Cellular Mechanisms and Therapeutic advances; 1995 May 15-17; Washington D.C.; George Washington School of Medicine
12. Beckman JS, Carson M, Smith CD, Koppenol WH. ALS, SOD and peroxynitrite [letter]. Nature 1993;364:584
13. Good PF, Werner P, Hsu A, Olanow CW, Perl DP. Evidence for neuronal oxidative damage in Alzheimer's disease. Am J Pathol 1996;149:21-28
14. Bruijn LI, Beal MF, Becher MW, et al. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked Superoxide dismutase 1 mutant. Proc Natl Acad Sci USA 1997;94:7606-11
15. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 1997;17:2653-57
16. Hunot S, Boissere F, Faucheux B, et al. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 1996;72:355-63
17. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J. NMDA-dependent Superoxide production and neurotoxicity. Nature 1993;364:535-37
18. Beckman JS, Ischiropoulos H, Zhu L, et al. Kinetics of Superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite. Arch Biochem Biophysics 1992;298:438-45
19. Albin RL, Greenamyre JT. Alternative excitotoxic hypotheses. Neurology 1992;42:733-38
20. Hantraye P, Brouillet E, Ferrante R, et al. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nature Med 1996;2:1017-21
21. Goldman JT, Yen S-H, Chiu F-C, Peress NS. Lewy bodies of Parkinson's disease contain neurofilament antigens. Science 1983;221:1082-84
22. Forno L. The Lewy body in Parkinson's disease. Adv Neurol 1986;45:35-43
23. Schmidt ML, Murray J, Lee VM, Hill WD, Wertkin A, Trojanowski JQ. Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am J Pathol 1991;139:53-65